# AMPLIFY ETF TR WEIGHT LOSS DRUG

AMPLIFY ETF TR WEIGHT LOSS DRUG is a security (CUSIP 032108532) tracked across SEC portfolio filings. 5 institutional managers reported $919K on Form 13F as of 2026-03-31.

## Summary

- Issuer: AMPLIFY ETF TR
- Class: WEIGHT LOSS DRUG
- CUSIP: 032108532
- 13F holders: 5
- 13F value: $919K
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [CITADEL ADVISORS LLC](https://search.stillhousedata.com/firm/148826) | MIAMI, FL | $670K | 27,241 |
| [GTS SECURITIES LLC](https://search.stillhousedata.com/firm/149224) | NEW YORK, NY | $240K | 9,761 |
| [Godfrey Financial Associates, Inc.](https://search.stillhousedata.com/firm/126189) | GLENMONT, NY | $5K | 203 |
| UBS Group AG | Zurich, V8 | $5K | 193 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/032108532.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.